ARDX
Ardelyx, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.78
+1.89%0
Insider buys (3m)
24
Insider sells (3m)
-$1.4M
Net value (3m)
-32.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 25, 2026 | Reilly Joseph James · officer: See Remarks | Sale | 2,872 | $3.86 |
| Aug 25, 2026 | Brady James Parker · officer: Chief Human Resources Officer | Sale | 1,976 | $3.86 |
| Aug 25, 2026 | Brady James Parker · officer: Chief Human Resources Officer | Sale | 13,160 | $3.86 |
| Aug 25, 2026 | Foster Eric Duane · officer: Chief Commercial Officer | Sale | 2,598 | $3.86 |
| Aug 25, 2026 | Kelliher Mike · officer: Chief Business Officer | Sale | 2,002 | $3.86 |
| Aug 25, 2026 | RAAB MICHAEL · director, officer: President & CEO | Sale | 8,411 | $3.86 |
| Aug 25, 2026 | RAAB MICHAEL · director, officer: President & CEO | Sale | 15,976 | $3.86 |
| Aug 25, 2026 | Williams Laura A · officer: Chief Patient Officer | Sale | 2,430 | $3.86 |
| Aug 25, 2026 | Foster Eric Duane · officer: Chief Commercial Officer | Sale | 3,389 | $3.86 |
| Aug 25, 2026 | Bishop John E · officer: See Remarks | Sale | 2,469 | $3.86 |
| Aug 25, 2026 | Kelliher Mike · officer: Chief Business Officer | Sale | 3,104 | $3.86 |
| Aug 25, 2026 | Foster Eric Duane · officer: Chief Commercial Officer | Sale | 2,575 | $3.86 |
| Aug 25, 2026 | RAAB MICHAEL · director, officer: President & CEO | Sale | 19,178 | $3.86 |
| Aug 25, 2026 | Williams Laura A · officer: Chief Patient Officer | Sale | 1,734 | $3.86 |
| Aug 25, 2026 | Bishop John E · officer: See Remarks | Sale | 17,281 | $3.86 |
| Aug 25, 2026 | Kelliher Mike · officer: Chief Business Officer | Sale | 2,652 | $3.86 |
| Aug 25, 2026 | RAAB MICHAEL · director, officer: President & CEO | Sale | 15,009 | $3.86 |
| Aug 25, 2026 | Williams Laura A · officer: Chief Patient Officer | Sale | 3,089 | $3.86 |
| Aug 25, 2026 | Hohenleitner Susan · officer: Chief Financial Officer | Sale | 1,558 | $3.86 |
| Aug 25, 2026 | Reilly Joseph James · officer: See Remarks | Sale | 1,110 | $3.86 |
| Aug 25, 2026 | Williams Laura A · officer: Chief Patient Officer | Sale | 3,486 | $3.86 |
| Jul 17, 2026 | RAAB MICHAEL · director, officer: President & CEO | Sale | 41,668 | $5.06 |
| Jul 17, 2026 | RAAB MICHAEL · director, officer: President & CEO | M-Exempt | 20,834 | $0.99 |
| Jun 22, 2026 | Williams Laura A · officer: Chief Patient Officer | M-Exempt | 31,000 | $0.99 |
| Jun 22, 2026 | Williams Laura A · officer: Chief Patient Officer | Sale | 81,898 | $5.99 |
| Jun 18, 2026 | Parsey Merdad · director | A-Award | 26,455 | $0.00 |
| Jun 18, 2026 | Cadoret-Manier Onaiza · director | A-Award | 26,455 | $0.00 |
| Jun 18, 2026 | MOTT DAVID M · director | A-Award | 26,455 | $0.00 |
| Jun 18, 2026 | Bhanji Muna · director | A-Award | 26,455 | $0.00 |
| Jun 18, 2026 | Cadoret-Manier Onaiza · director | A-Award | 39,715 | $5.67 |
Institutional positioning
13F filings over the trailing two quarters
New 94Increased 196Reduced 147Sold out 33
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 23,504,630 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 21,164,132 | May 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 18,043,970 | May 15, 2026 |
| Rubric Capital Management LP | Increased | 16,202,700 | Aug 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 14,272,473 | Aug 14, 2026 |
| STATE STREET CORP | Increased | 13,604,307 | May 15, 2026 |
| STATE STREET CORP | Reduced | 13,356,128 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 10,471,494 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 10,365,512 | May 15, 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | Increased | 9,546,732 | Aug 14, 2026 |
| JANUS HENDERSON GROUP PLC | Reduced | 8,371,234 | May 18, 2026 |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | Reduced | 8,169,369 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 8,026,774 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 6,661,693 | May 8, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 6,401,736 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 25, 2026